Market Capitalization (Millions $) |
73 |
Shares
Outstanding (Millions) |
27 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-39 |
Cash Flow (TTM) (Millions $) |
21 |
Capital Exp. (TTM) (Millions $) |
0 |
Eliem Therapeutics Inc
Eliem Therapeutics Inc is a pharmaceutical company that focuses on developing innovative therapies for neurological and mental health disorders. The company is committed to discovering and delivering breakthrough treatments that can improve patient outcomes and quality of life. They utilize cutting-edge research and technology to develop novel therapeutics that address unmet medical needs in the field of neuroscience. Eliem Therapeutics Inc aims to make a significant impact on the lives of individuals suffering from these disorders.
Company Address: PMB #117 Wilmington 98053 DE
Company Phone Number: 354-3689 Stock Exchange / Ticker: NASDAQ ELYM
|